InsiderClue
Insiders · Profile

GILMAN STEVEN C

Director at Vericel · Director at Akebia Therapeutics · Director at SCYNEXIS. Filing since 4 Sep 2018. CIK 0001379970

VCEL Vericel Corp Director · 12 trades AKBA Akebia Therapeutics, Inc. Director · 4 trades SCYX SCYNEXIS INC Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
VCEL Vericel Corp
16 Oct 2024
Director
Sold on a plan
5,833
$241.25K
34.7%
VCEL Vericel Corp
2 Oct 2024
Director
Sold on a plan
5,833
$235.36K
34.7%
VCEL Vericel Corp
18 Sep 2024
Director
Sold on a plan
5,834
$265.68K
34.7%
VCEL Vericel Corp
4 Sep 2024
Director
Sold on a plan
5,000
$242.90K
31.3%
AKBA Akebia Therapeutics, Inc.
3 Jun 2022
Director
Sold, plan not stated
4,567
$1.65K
9.5%
VCEL Vericel Corp
29 Apr 2022
Director
Sold, plan not stated
900
$27.85K
14.8%
VCEL Vericel Corp
29 Nov 2021
Director
Sold, plan not stated
5,000
$195.86K
58.8%
VCEL Vericel Corp
27 Oct 2021
Director
Sold, plan not stated
5,000
$252.87K
58.8%
VCEL Vericel Corp
30 Sep 2021
Director
Sold, plan not stated
5,000
$244.26K
58.8%
AKBA Akebia Therapeutics, Inc.
7 Jun 2021
Director
Sold, plan not stated
4,567
$15.16K
8.7%
SCYX SCYNEXIS INC
21 Dec 2020
Director
Bought
4,000
$25.00K
opened
AKBA Akebia Therapeutics, Inc.
8 Jun 2020
Director
Sold, plan not stated
4,567
$55.17K
10.5%
AKBA Akebia Therapeutics, Inc.
20 Nov 2019
Director
Bought
5,800
$19.89K
24.2%
VCEL Vericel Corp
1 May 2019
Director
Sold, plan not stated
7,500
$126.09K
100%
VCEL Vericel Corp
28 Feb 2019
Director
Sold, plan not stated
7,500
$135.13K
100%
VCEL Vericel Corp
3 Dec 2018
Director
Sold, plan not stated
8,500
$150.91K
100%
VCEL Vericel Corp
4 Sep 2018
Director
Sold, plan not stated
9,000
$108.27K
100%
17 decisions on file.